Company Number: 14410047

Analysis Date: 2025-07-20 18:36 UTC

Financial Health Assessment for CYBOTIFY LTD (as of 31 October 2024)

---

1. Financial Health Score: B

Explanation:
CYBOTIFY LTD demonstrates a solid financial foundation with strong net current assets and a healthy increase in shareholders' funds over a short operating period (since incorporation in 2022). The company has maintained positive working capital and net assets, indicating good liquidity and solvency. However, the scale of operations is still small with limited cash reserves, and there are some minor concerns about the increase in tax liabilities. Overall, the company shows promising financial wellness but still has room to grow and fortify its financial resilience.

---

2. Key Vital Signs

Metric	2024 Value (£)	2023 Value (£)	Interpretation
Cash at Bank	34,802	3,718	A healthy increase in cash reserves, indicating improved liquidity and operational cash flow.
Current Liabilities	1,180	1,124	Stable and low short-term obligations relative to cash and assets.
Net Current Assets	33,622	2,594	Strong positive working capital, signaling good short-term financial health.
Net Assets / Shareholders’ Funds	33,622	2,594	Significant growth in equity, showing retained earnings or capital injection supporting stability.
Tax and Social Security Creditors	7,396	609	Sharp increase in tax liabilities, potentially a symptom needing close monitoring or management.
Loans from Directors	(6,678)	95	Director loans fluctuate, showing some internal financing adjustments.
Average Employees	1	1	Small staffing level, consistent with a micro or small enterprise.

---

3. Diagnosis: Financial Condition Analysis

• Liquidity ("Healthy Cash Flow"):
  The company’s cash position has improved markedly, from £3,718 to £34,802, indicating a strong inflow of cash or successful capital raising. Cash is more than sufficient to cover current liabilities (£1,180), which suggests a healthy short-term liquidity position.

• Working Capital ("Robust Vital Signs"):
  Net current assets have grown substantially to £33,622, expressing a strong buffer to meet short-term obligations. This suggests the company is not under immediate financial distress and can cover operational expenses comfortably.

• Solvency ("Stable Core"):
  Net assets equate to shareholders' funds and have increased significantly—this is the backbone of financial stability. The company is solvent with positive equity, which is a good sign for creditors and investors.

• Tax Liability ("Symptom of Potential Strain"):
  The jump in tax and social security creditors from £609 to £7,396 signals a potential timing issue or tax payment deferral. This could be a symptom of cash management challenges or tax planning that requires attention to avoid future penalties or cash flow stress.

• Director Loans ("Internal Financing Adjustment"):
  The movement in director loans from a small positive (£95) to a negative balance (£6,678) implies that the director has either lent money to the company or repaid loans. This internal financing can be a healthy sign if managed properly but should be tracked carefully.

• Scale and Growth ("Early Stage"):
  Established in late 2022, the company is in its growth phase. The increase in equity and cash suggests successful initial operations or investment, but the scale remains small with one employee, consistent with a micro-enterprise.

---

4. Recommendations

1. Monitor and Manage Tax Liabilities:
   The large increase in tax and social security creditors needs investigation. Ensure tax filings are timely and payments scheduled to avoid penalty risks and cash flow disruption. Consider consulting a tax advisor to optimize the company’s tax position.

2. Maintain Cash Flow Discipline:
   Continue to build on the positive cash flow trend. Keep close watch on working capital cycles, especially if business grows, to avoid liquidity crunches.

3. Plan for Growth and Staffing:
   With only one employee, scaling up will require strategic planning on hiring and resource allocation to sustain growth without overextending finances.

4. Document Director Loans Clearly:
   Maintain transparent records of director loans to avoid confusion over liabilities and ensure compliance with company law.

5. Prepare for Future Financial Reporting:
   As the company grows, consider moving beyond exemption thresholds requiring fuller audits and comprehensive financial reporting to boost investor confidence.

---